Bone Solutions appoints CMO (chief medical officer):
This article was originally published in Clinica
Executive Summary
Dallas, Texas-based orthopaedic adhesive developer Bone Solutions has named Dr Stephen Schendel, professor and former head of Stanford University's plastic and reconstructive surgery department, chief medical officer. Bone Solutions is developing OsteoCrete for use as a bone filler and cement in orthopaedic and dental repair. The bioabsorbable magnesium-based compound incorporates the company's BioHesive technology and is said to be able to attach not only bone to bone, but also ligaments and tendons to bone.
You may also be interested in...
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.